Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 9.51% on an annualized basis producing an average annual return of 17.4%. Currently, Vertex Pharmaceuticals has a market capitalization of $92.58 billion.
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 20 years ago, it would be worth $2,508.09 today based on a price of $359.48 for VRTX at the time of writing.
Vertex Pharmaceuticals's Performance Over Last 20 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.